Daré Bioscience, Inc.
Daré Bioscience, Inc. (DARE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DARE · as of Jun 8, 2026
Key Statistics
Explore Daré Bioscience, Inc. Data
dare stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 100.0%
The DARE analyst consensus is Buy, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +536.60% upside from the current price of $1.89.
Competitors & Peers
dare competitorsDARE
ADTX
AIMD
ANL
ASBP
ATHAStock Performance
Full HistoryAbout Daré Bioscience, Inc.
Daré Bioscience, Inc. a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the …
what is daré bioscience, inc. · dare stock overview · daré bioscience, inc. company profile · who is daré bioscience, inc. ceo · dare NASDAQ · daré bioscience, inc. headquarters · daré bioscience, inc. business segments
About Stock Overview & Key Data
Daré Bioscience, Inc. (DARE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 10, 2014. As of the latest trading session, DARE stock price is $1.89, with a market capitalization of $17.9M. The stock has returned -39.78% over the past 12 months and -2.33% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Daré Bioscience, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, Daré Bioscience, Inc. reported revenue of $1.0M and net income of -$13.4M. For detailed data — including Daré Bioscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Daré Bioscience, Inc. (DARE) stock price is $1.89. The stock is traded on NASDAQ under the ticker symbol DARE. The 52-week range is $1.27 – $9.19.